Trial NCT01728259

View at ClinicalTrials.gov 
Org. Study IDs: 2011-155

Last trial update was posted on 2023-05-09

MeSH Interventions

Bortezomib Dexamethasone Pomalidomide

MeSH Conditions

Amyloidosis Immunoglobulin Light-chain Amyloidosis Multiple Myeloma

Other Conditions

Light Chain Deposition Disease Primary Systemic Amyloidosis

Stopping Reasons

FDA placed the study on a clinical hold, due to the concerns by the FDA and Health Canada, Celgene decided to permanently close the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID